A detailed history of Plante Moran Financial Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 642 shares of VTRS stock, worth $7,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
642
Previous 773 16.95%
Holding current value
$7,415
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$10.05 - $12.02 $1,316 - $1,574
-131 Reduced 16.95%
642 $6,000
Q4 2023

Feb 05, 2024

SELL
$8.77 - $10.85 $1,192 - $1,475
-136 Reduced 14.96%
773 $8,000
Q3 2023

Nov 07, 2023

SELL
$9.59 - $11.35 $11,229 - $13,290
-1,171 Reduced 56.3%
909 $8,000
Q2 2023

Aug 07, 2023

BUY
$9.02 - $10.29 $10,643 - $12,142
1,180 Added 131.11%
2,080 $20,000
Q1 2023

May 08, 2023

SELL
$9.2 - $12.26 $2,907 - $3,874
-316 Reduced 25.99%
900 $8,000
Q4 2022

Feb 09, 2023

BUY
$8.72 - $11.56 $209 - $277
24 Added 2.01%
1,216 $13,000
Q3 2022

Nov 02, 2022

BUY
$8.48 - $11.13 $8 - $11
1 Added 0.08%
1,192 $10,000
Q2 2022

Aug 02, 2022

SELL
$9.95 - $12.27 $666 - $822
-67 Reduced 5.33%
1,191 $12,000
Q1 2022

May 06, 2022

SELL
$9.81 - $15.4 $2,305 - $3,619
-235 Reduced 15.74%
1,258 $14,000
Q4 2021

Feb 09, 2022

SELL
$12.09 - $14.68 $1,450 - $1,761
-120 Reduced 7.44%
1,493 $20,000
Q3 2021

Nov 08, 2021

SELL
$13.25 - $15.13 $1,735 - $1,982
-131 Reduced 7.51%
1,613 $22,000
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $13,410 - $16,699
-1,034 Reduced 37.22%
1,744 $25,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $10,967 - $14,961
-807 Reduced 22.51%
2,778 $39,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $51,265 - $67,182
3,585 New
3,585 $67,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.